Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > What?

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Apr 27, 2023 10:16am

111 Views

Post# 35416835

RE:RE:RE:RE:RE:RE:RE:What?

Yep, a bit larger dose might be key? We'll probably see that after AA though. I think they will have what they need to apply for BTD in a month. And after that AA sometime later this year. IMO

When they apply for BTD the CR %s should still be pretty high. Not 67% but ~ 50%. :-)

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec